1 |
B2RY58: Hyperpolarization-activated, cyclic nucleotide-gated K+ 4 {ECO:0000313|EMBL:AAI58107.1}; MCG22630 {ECO:0000313|EMBL:EDL25959.1}; Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 {ECO:0000313|Ensembl:ENSMUSP00000034889}
|
Pubmed References:
2
|
expand
|
|
|
2 |
O88703: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2; Brain cyclic nucleotide-gated channel 2; BCNG-2; Hyperpolarization-activated cation channel 1; HAC-1
|
Pubmed References:
1
|
expand
|
|
|
3 |
O88704: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1; Brain cyclic nucleotide-gated channel 1; BCNG-1; Hyperpolarization-activated cation channel 2; HAC-2
|
Pubmed References:
1
|
expand
|
|
|
4 |
O88705: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3; Hyperpolarization-activated cation channel 3; HAC-3
|
Pubmed References:
1
|
expand
|
|
|
5 |
P00520: Tyrosine-protein kinase ABL1; 2.7.10.2; Abelson murine leukemia viral oncogene homolog 1; Abelson tyrosine-protein kinase 1; Proto-oncogene c-Abl; p150
|
Pubmed References:
3
|
expand
|
|
|
6 |
P39688: Tyrosine-protein kinase Fyn; 2.7.10.2; Proto-oncogene c-Fyn; p59-Fyn
|
Pubmed References:
3
|
expand
|
|
|
7 |
P51637: Caveolin-3; M-caveolin
|
Pubmed References:
1
|
expand
|
|
|